Loading page…

Report overview

The report presents CH Biotech's 2021 ESG performance, including consolidated revenue of NT$1,018,505 thousand, greenhouse gas emissions of 3,434.2 metric tons, and water consumption of 20,234 m3. It describes a systematic materiality process that identified nine material topics. The report also records 132 Group employees worldwide, zero occupational fatalities, and independent Type 1 moderate assurance by SGS Taiwan Ltd.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 1 June 2022
Language
Pages
File size

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Assurance

Provider
Standard
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 2 emissions
Energy consumption
Water consumption
Waste
Employees
Women in management
Workplace fatalities

Materiality

Assessment
Basis
Matrix

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services

ESG Report

Report overview

Document

Standards & Assurance

Standards

Commitments

Ratings

Assurance

ESG & Materiality

ESG data

Materiality

Build your research dataset.

ESG Report

Report overview

Document

Standards & Assurance

Standards

Commitments

Ratings

Assurance

ESG & Materiality

ESG data

Materiality

Build your research dataset.